RxDoctor Payments Data

Monique Allman

Physician Assistant · Katy, TXNPI 1659605723

Payments from drug & device makers

$11,167in general payments, 2019–2025

Across 262 payments — averaging $42.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$3K
  • AstraZeneca$2K
  • GSK$1K
  • Optinose US, Inc.$565
  • Takeda Pharmaceuticals U.S.A., Inc.$506
  • Pfizer$254
  • plus $3K from 25 others

What the payments were for

  • Consulting fees$2,37521%
  • Travel & lodging$7727%
  • Food & beverage$7,92671%
  • Education$941%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,167 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$25,862
Breo ElliptaFluticasone/Vilanterol11$8,248
Azelastine Hcl95$2,401
Ipratropium Bromide40$1,261
Fluocinolone Acetonide Oil17$890
Fluticasone Propionate70$888
Montelukast Sodium69$825
Levocetirizine Dihydrochloride24$621
Albuterol Sulfate HfaAlbuterol Sulfate21$561
Mupirocin17$403
Hydroxyzine Hcl15$245
Cefdinir13$181
Methylprednisolone23$158
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$156
Azithromycin30$119

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$1,196$34,10937 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Katy

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →